Anteris Technologies Global (AVR) Competitors $5.57 +0.57 (+11.40%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AVR vs. BVS, AVNS, ZIMV, KIDS, TMCI, CBLL, SMLR, DCTH, BFLY, and RXSTShould you be buying Anteris Technologies Global stock or one of its competitors? The main competitors of Anteris Technologies Global include Bioventus (BVS), AVANOS MEDICAL (AVNS), ZimVie (ZIMV), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), CeriBell (CBLL), Semler Scientific (SMLR), Delcath Systems (DCTH), Butterfly Network (BFLY), and RxSight (RXST). These companies are all part of the "medical equipment" industry. Anteris Technologies Global vs. Its Competitors Bioventus AVANOS MEDICAL ZimVie OrthoPediatrics Treace Medical Concepts CeriBell Semler Scientific Delcath Systems Butterfly Network RxSight Anteris Technologies Global (NASDAQ:AVR) and Bioventus (NASDAQ:BVS) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability. Which has stronger earnings & valuation, AVR or BVS? Bioventus has higher revenue and earnings than Anteris Technologies Global. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnteris Technologies Global$2.70M74.39-$76.29MN/AN/ABioventus$573.28M1.04-$33.54MN/AN/A Do institutionals & insiders hold more shares of AVR or BVS? 62.9% of Bioventus shares are held by institutional investors. 4.0% of Anteris Technologies Global shares are held by insiders. Comparatively, 33.0% of Bioventus shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts rate AVR or BVS? Anteris Technologies Global currently has a consensus target price of $16.50, indicating a potential upside of 196.23%. Given Anteris Technologies Global's stronger consensus rating and higher possible upside, research analysts plainly believe Anteris Technologies Global is more favorable than Bioventus.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anteris Technologies Global 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Bioventus 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is AVR or BVS more profitable? Anteris Technologies Global has a net margin of 0.00% compared to Bioventus' net margin of -0.03%. Bioventus' return on equity of 23.04% beat Anteris Technologies Global's return on equity.Company Net Margins Return on Equity Return on Assets Anteris Technologies GlobalN/A N/A N/A Bioventus -0.03%23.04%6.04% Does the media prefer AVR or BVS? In the previous week, Anteris Technologies Global had 3 more articles in the media than Bioventus. MarketBeat recorded 4 mentions for Anteris Technologies Global and 1 mentions for Bioventus. Anteris Technologies Global's average media sentiment score of 0.99 beat Bioventus' score of 0.00 indicating that Anteris Technologies Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bioventus 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryAnteris Technologies Global beats Bioventus on 7 of the 13 factors compared between the two stocks. Get Anteris Technologies Global News Delivered to You Automatically Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVR vs. The Competition Export to ExcelMetricAnteris Technologies GlobalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$180.31M$6.79B$5.79B$10.15BDividend YieldN/A1.23%5.69%4.61%P/E RatioN/A25.5274.5925.92Price / Sales74.3962.88449.5483.33Price / CashN/A21.6337.0859.91Price / Book3.205.0012.156.29Net Income-$76.29M$176.38M$3.28B$270.85M7 Day Performance33.89%1.00%0.98%3.36%1 Month Performance50.13%3.19%7.20%6.41%1 Year PerformanceN/A12.30%63.06%28.26% Anteris Technologies Global Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVRAnteris Technologies Global1.7161 of 5 stars$5.57+11.4%$16.50+196.2%N/A$180.31M$2.70M0.00138News CoverageHigh Trading VolumeBVSBioventus0.9948 of 5 stars$7.19+1.3%N/AN/A$594.47M$573.28M14.081,200AVNSAVANOS MEDICAL2.1283 of 5 stars$12.70+0.3%N/A-47.3%$589.47M$687.80M-1.262,227Positive NewsZIMVZimVie1.255 of 5 stars$18.85-0.2%$17.75-5.8%+16.6%$531.78M$443.40M-26.931,770News CoveragePositive NewsKIDSOrthoPediatrics4.3576 of 5 stars$20.91+1.0%$34.14+63.3%-34.8%$524.21M$204.73M-11.68200Positive NewsTMCITreace Medical Concepts2.5289 of 5 stars$7.17flat$9.83+37.1%+43.9%$452.95M$213.75M-9.08250Positive NewsCBLLCeriBell2.5098 of 5 stars$11.80-4.3%$32.14+172.4%N/A$432.59M$65.44M-3.95N/APositive NewsSMLRSemler Scientific2.9855 of 5 stars$28.12+0.1%$81.75+190.7%+20.2%$416.46M$56.29M11.57120DCTHDelcath Systems2.9843 of 5 stars$11.65+5.0%$24.50+110.3%+11.7%$407.52M$37.21M233.0060Positive NewsBFLYButterfly Network3.1524 of 5 stars$1.56+1.6%$3.00+92.9%-19.7%$391.46M$82.06M-5.55460Positive NewsRXSTRxSight1.8679 of 5 stars$8.89+5.0%$10.00+12.5%-82.7%$363.74M$147.06M-11.11220Trending News Related Companies and Tools Related Companies BVS Alternatives AVNS Alternatives ZIMV Alternatives KIDS Alternatives TMCI Alternatives CBLL Alternatives SMLR Alternatives DCTH Alternatives BFLY Alternatives RXST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AVR) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anteris Technologies Global Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anteris Technologies Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVR Stock Alerts